Clinical Trials Directory

Trials / Terminated

TerminatedNCT01048567

Efficacy and Safety of Lactobacillus Acidophilus/Rhamnosus Combination for the Prevention of Antibiotic-associated Diarrhea in the Elderly

Use of Lactobacillus Acidophilus/Rhamnosus Complex for the Prevention of Antibiotic-associated Diarrhea in Elderly Hospitalized Patients

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
7 (actual)
Sponsor
Vancouver Island Health Authority · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether Lactobacillus acidophilus/rhamnosus complex is effective in the prevention of antibiotic-associated diarrhea (AAD) in the elderly.

Detailed description

Antibiotic-associated diarrhea (AAD) is a common adverse drug reaction, occurring in 5-35% of patients, and is of significant consequence to hospitalized patients. Patients who develop AAD are more likely to experience a longer hospital stay, incur higher medical costs, and develop other co-morbidities. Clostridium difficile infection (CDI) accounts for approximately 15-25% of AAD cases and is a significant cause of morbidity and mortality in hospitalized geriatric patients. A preventative measure that has been suggested for AAD and CDI is the use of probiotics. Although probiotics have been used for a wide range of indications, including the prevention and treatment of AAD and CDI, there is lack of data regarding efficacy of these products. Hospitalized elderly patients are at significant risk of developing AAD and CDI and prevention of AAD and CDI in this population may contribute to a reduction in morbidity, length of hospital stay, medical costs, and potentially mortality.

Conditions

Interventions

TypeNameDescription
OTHERLactobacillus acidophilus/rhamnosus2 capsules (at least 2 billion cells per capsule) three times daily for duration of antibiotic therapy
OTHERPlacebo2 capsules three times daily for entire duration of antibiotic therapy.

Timeline

Start date
2011-09-01
Primary completion
2011-10-01
Completion
2011-10-01
First posted
2010-01-13
Last updated
2013-12-19

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01048567. Inclusion in this directory is not an endorsement.